A Randomized Controlled Clinical Trial for Osteopeptides in Treating Early Knee Osteoarthritis
- Conditions
- Knee osteoarthritis
- Registration Number
- ITMCTR1900002576
- Lead Sponsor
- Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Early knee osteoarthritis;
2. Aged <= 60 years; there is no limit to men and women;
3. Cartilage injury was found on MRI of knee joint;
4. Agree and sign an informed consent form.
1. Secondary KOA;
2. Those complicated with cerebrovascular, liver, kidney, mental diseases and other serious diseases;
3. Suffering from joint tuberculosis, tumor, infectious arthritis, rheumatoid arthritis, ankylosing spondylitis, gout, psoriasis and other systemic diseases;
4. There is a history of knee joint trauma, fracture and operation;
5. Pain attack accompanied by fever;
6. The course of disease is not self-limiting and progressive aggravation;
7. Patients who are unable to complete case data collection and have poor compliance.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method magnetic resonance imaging T2-mapping imaging;
- Secondary Outcome Measures
Name Time Method The Western Ontario and McMaster Universities Osteoarthritis Index;